Loading...
2017 Sessions 2017-10-15T11:54:41+00:00
Saturday
Sunday
PRE-CON BOOTCAMP (Ticketed Event not included in main conference registration)
Friday April 21, 2017

8:00 AM9:00 PM
Main on-site registration will be located at: Sheraton Centre Toronto Hotel 123 Queen St. W., Toronto.
    9:00 AM9:45 AM

    Network with your fellow Boot Campers while enjoying fresh brewed coffee and a continental breakfast.

      9:45 AM10:10 AM
      (Workshop Presentation) There has never been a more exciting time to be in the cannabis industry.  In the U.S.A. more than 20% of the population now lives in a state where recreational cannabis is legal.  More than 65% of the country lives in a state where medical cannabis is legal.  Canada is preparing to become the first country in the world to legalize marijuana for anyone who is of age.  Deloitte recently forecast that the size of the Canadian cannabis market could exceed $22.6 Billion in the next few years.  Time Magazine said that marijuana sales in Canada could outpace the sales of alcohol in our country.  More and more countries around the world are legalizing.  This is marijuana’s moment – the question is where do you fit in?  Dooma Wendschuh entered the cannabis industry in 2013 and built one of the most talked about brands in the space.  He’s now on his second venture – a groundbreaking beverage company called Province in Toronto.  He’ll share his experiences and battle scars.  We’ll cover the history of the industry from the discovery of THC in the 60’s to the endocannabinoid system in 1991 to California’s legalization of medical cannabis in 1996, to the political changes which set the stage for the fastest growing multi-billion-dollar industry in the world.  We’ll learn about the three different markets for cannabis, and about the different types of cannabis businesses, and products, and the technologies and innovations pushing the industry forward.  This is Cannabis 101.
      10:15 AM11:00 AM
      Kevin Hall, Executive Director of Chronic Pain Toronto and Chief Operating Officer of International Cannabis Solutions, will take you through an overview of Cannabis and the over 400 different compounds, it’s history and how it fits into the four pillars of a fulsome medical treatment plan.  He will also discuss the illnesses and symptoms it can help with, along with responsible use.

      • Kevin Hall
        Executive Director, Chronic Pain Toronto
      11:05 AM11:30 AM
      (Workshop Presentation) Legal & Regulatory & Compliance for Banking, Payment Processing & Cash Management for cannabis merchants in the new ecosystem.
      •   Traditional banks and payment’s companies in Canada are reluctant to embrace the cannabis industry, what legal and regulatory issues does industry need to address to gain access to banking;
      • What does the payments landscape look like for the cannabis industry now, where it is heading as legalization for recreational use becomes a reality;
      • Why is the cannabis industry viewed as ‘high-risk’, what steps does it need to take to ensure it is fully compliant with the payments system rules;
      • When ‘Fintech’ is described as revolutionizing payments – Cannabis was once a ‘cash-only’ industry and now struggles to gain acceptance from the payments space, what is the disconnect and how does the marijuana space navigate this unfamiliar territory and gain acceptance in the financial services world?
      11:35 AM12:00 PM
      (Workshop Presentation) Hard science will meet the demand of the sophisticated cannabis consumer! Ralph Morgan founded Organa Brands’ Organa Labs in 2010, which is the oldest and longest running supercritical CO2 cannabis oil extraction lab in the world. Today, Organa Brands licenses eleven Organa Labs manufacturing facilities in ten US states and Jamaica and distributes oil and vaporizer products in seven European countries and through 1,200 US dispensaries. The popularity of vaping and edibles will likely push consumer demand for cannabis oil to 50 percent share of the 2017 US cannabis market. Already, labs are producing cannabis oils with distinctive profiles that are rich in flavor and pure in formulation. Cannabis oil can be extracted to the level of 99% active THC. Morgan will explain the evolution of cannabis oil extraction in the context of consumer preferences. His presentation is structured to help Canada’s cannabis entrepreneurs understand the value, profit potential and consumer wellness benefits of responsibly manufacturing lab grade, pharmaceutical- quality cannabis oil.
      12:00 PM12:45 PM
      12:45 PM1:10 PM
      (Workshop Presentation) If you're a purveyor of medical cannabis, you may not think you are performing R&D – but you likely are. And the good news is that you may be eligible for valuable government tax credits for some of the work you are doing. Canada's Scientific Research & Experimental Development (SR&ED) program provides generous financial incentives to encourage scientific and technological advances. Your business could receive a credit of up to 66% of qualifying expenditures. Don't miss out on significant tax savings. Attend this session to find out which of your activities may qualify for SR&ED tax credits and what you need to do to harvest these benefits.
      1:15 PM1:40 PM
      (Workshop Presentation) Businesses are clamouring to get a foothold in Canada’s emerging legal cannabis sector. With so many new entrants, businesses must find ways to distinguish themselves and their products and services. This workshop  will cover all aspects of branding a cannabis sector business and individual cannabis related products and services. In this session an intellectual property lawyer and specialist will discuss (1) the benefits of trademarks and other types of IP protection for cannabis sector businesses; (2) how to secure trademark protection for cannabis products and services in Canada and the United States; and (3) legal obstacles to registering trademarks for cannabis related products and services in the United States; and (4) branding strategies.
      1:45 PM2:10 PM
      (Workshop  Presentation) Canada’s regulated cannabis sector continues to undergo fast-paced change with full legalization looming large on the horizon. One of the most talked-about and controversial issues in the regulation debate is the present and future mandatory security requirements. In this session, Canada’s top cannabis industry security consultant will discuss: (1) the crime and security risks faced by regulated cannabis sector businesses; (2) the current ACMPR security requirements; and (3) the main security priorities under a legalized recreational market.

      • David Hyde
        Owner & Principal Consultant, David Hyde & Associates
      2:15 PM2:40 PM
      (Workshop Presentation) This fast-paced, highly interactive program comes from the master of modern cannabis branding and marketing. It combines cutting-edge academic thinking and proven techniques to inspire and enable you to create and manage a powerful brand. Guided by Jared Mirsky, CEO and Founder of Online Marijuana Design — the largest cannabis branding agency in the world and two-time Dope Magazine Industry Awards winner for "Best Cannabis Design Firm" —you’ll gain insight into his innovative approaches and learn how to apply them in practice through real-world cases and structured exercises. You’ll learn how to use marketing and branding to build a profitable and enduring business and gain new insights into the importance and value of a strongly differentiated brand. You’ll come away empowered with new knowledge and skills you can apply immediately to increase customer loyalty, competitive advantage, and profitability. KEY TAKEAWAYS:
      • The Creative Brief Process (How to Prepare for Branding)
      • Logo Design & Development (The Value of a great logo and differentiation)
      • Brand Strategy (Planning for the future the right way, the first time)
      • Copywriting (How to Story Tell the right way)
      • Packaging (Do's, don't, tips and things to consider when going through this process)
      • Sales Collateral (How to create effective Sales Collateral)
      • Website Design (What your website should do, have and say about your company)
      2:40 PM3:00 PM
      The Networking Coffee Break is a chance to meet and discuss with key players in the industry.
        3:00 PM3:25 PM
        (Workshop Presentation) Keep 100% of your equity and  grow your business through working  capital , real estate loans and equipment leases . The Marijuana Money  Man is coming in from Colorado to share case studies  of the $27  million in financing he has arranged for cannabis companies .

        • Scott Jordan
          Director of Business Development, Dynamic Alternative Finance
        3:30 PM3:55 PM
        (Workshop Presentation) Just as Canada can teach the United States about access to healthcare, Colorado can help Canadians understand the best ways to access cannabis through independent retail stores. Prime Minister Trudeau promised to legalize, regulate and restrict access, yet Canada has not yet decided on how its citizens will obtain legal cannabis. Colorado was the first state to legalize cannabis for recreational use. Tim Cullen, CEO of Colorado Harvest Company, an industry pioneer, opened a vertically integrated medical cannabis cultivation and retail enterprise in 2009. Per Colorado law, retail shops could only sell the cannabis they grew. Colorado Harvest Company held 24 state licenses and was prepared to fully engage in a vertically integrated medical and recreational cannabis enterprise when Colorado retail medical cannabis centers opened to recreational customers on Jan. 1, 2014. Three shops, 65,000 sq. ft. of indoor cultivation space, 84 employees and 100,000 transactions per year, comprise Colorado Harvest Company, which draws tourists from around the globe as well as thousands of loyal customers who shop with confidence. Tim Cullen will offer the following considerations to help potential cannabis entrepreneurs.
        • Sustaining a profitable indoor grow for a vertically integrated cannabis business
        • Using technology, security, and meeting customer expectations.
        • Training your employees to be the face of your company.
        • Establishing a brand for your cannabis and your retail center.
        • Complying and communicating with regulators.
        • Managing proper and profitable vendor relationships.
        • Supporting advocacy organizations.
        • Competing with the black market as a message and a motive.
        • Good neighbor policies
        4:00 PM4:25 PM
        (Workshop Presentation) Cannabis QC testing is paramount to providing accurately labeled cannabis products- a critical step in proper cannabinoid dosing. There is a wide array of instrumentation and sample preparation techniques that can be applied to cannabis QC testing. Also, there are a number of organizations working independently to develop cannabis standards and methods. We will take a closer look at these needs, examine the changing landscape of cannabis science and review some of the movers and shakers impacting cannabis quality on a global level. We will explore topics beyond potency testing, including terpene profiling and the increasing importance of contaminant screening, including pesticides, residual solvents, heavy metals and microorganisms. This session will peer into a cannabis crystal ball and discuss the importance of genomics testing, personalized cannaceuticals and the future of cannabis analytical research. Lastly, Mr.Crossney will share opportunities where both experts and novices alike can gain first-hand experience in all aspects of the cannabis industry- from cultivation and pre-processing through extractions, sample preparation and quality control testing.

        • Josh Crossney
          President & Founder, jCanna & Cannabis Science Conference
        4:30 PM4:55 PM
        (Workshop Presentation) The session will begin with the current cannabis regulatory landscape and an overview of seed-to-sale compliance requirements. Participants will then engage in a discussion on the top 10 inventory best practices, focused on cultivation and manufacturing with broader application to distributors and retailers. The session is intended to be interactive and attendee participation is encouraged.   Actionable skills attendees will leave with: 1) Inventory management (batch vs. plant tracking) 2) Compliance management 3) Understanding of regulatory landscape
        5:00 PM5:30 PM
        (Workshop Presentation) Learn the ins and outs of cannabis cultivation from seasoned operator Alex Cooley of Solstice. Gain understanding of the process and practices from selecting a site to creating a finished product. Unique format that takes you through the steps but significantly engages audience members via an AMA format.

        DAY 1:  CONFERENCE & EXPO
        Saturday April 22, 2017
        8:30 AM9:30 AM
        *Ticketed Event* Cannabis businesses are like any other start-up enterprise, in that they are often operationally-successful but could use a little “seed money.” This can’t-miss executive breakfast is a chance for some targeted networking with prospective investors and possible equity partners. These conversations over coffee could be the most important you ever have.
        Moderator: Noa Kahner, CEO, Kahner Global
         
        9:00 AM9:45 AM
        (Exhibit Hall - Grand Ballroom) For Delegate Badge Holders & Exhibitors.
          9:40 AM9:45 AM
          Join us for the day’s opening remarks - a must-attend to make sure you don’t miss a thing!
            9:45 AM10:15 AM
            (Opening Keynote)

            • Bruce Linton
              Founder, Chairman & Chief Executive Officer , Canopy Growth Corporation
            10:25 AM10:55 AM
            (Presentation) This session will look at the cannabis market, market segmentation, market size estimates and growth drivers, investment risks, and recent dynamics in the industry for prospective cannabis investors to consider in both the U.S. and Canada.
            10:25 AM10:55 AM
            (Presentation) Jonathan and Joan will speak about the potential implications legalization will have for patients as well as their service providers. This session will cover areas including access, affordability, cost coverage, and research.

            • Joan Weir
              Director, Health and Dental Policy, Canadian Life and Health Insurance Association

            • Jonathan Zaid
              Founder & Executive Director, Canadians for Fair Access to Medical Marijuana
            10:55 AM11:15 AM
            (Outside Conference Seminar Rooms) For Delegate Badge Holders.
              11:15 AM12:00 PM
              (Presentation) This presentation will review pertinent facts about Cannabis and its medical effects, prevalence of use, associated harms (direct and indirect) and lessons learned from other jurisdictions. The final part of the lecture will focus on a Public Health approach to legalization of marijuana reflecting common recommendations of several national and provincial medical and public health organizations.
              11:15 AM12:00 PM
              (Presentation) Your cannabis business is very appealing to cyber criminals: trade secrets, financial information, confidential data of customers and vendors, email accounts, ransom money and more. Without proper protection, cyber threats can put your organization’s operations, reputation –  even its existence –  at risk. Cyber security is now an urgent business imperative for every cannabis company of every size and at every stage, from startup to exit. In this session you'll learn how cyber attacks are evolving and the steps you should take immediately to protect your business from cyber attackers.
              Presented by: MNP LLP mnp_logo343c_tag_stacked_for_web
              12:00 PM12:45 PM
              (Bonus Session: Panel Discussion on Main Stage) From the stigma of the 80s and 90s to the cultural paradigm shifts of today, marijuana use and endorsement by professional athletes has come a long way. Basketball legend Rick Barry, named one of the 50 greatest players by the NBA and snowboarding olympian Ross Rebagliati, gold medalist at the Nagano Olympics, speak of their personal experiences and address the changes in paradigm about cannabis and sports in the media and society over the last decades.
              12:45 PM1:40 PM
              (Keynote Presentation) Baby Boomers. GenX’ers. And Millennials. Three unique Canadian generations who have had unique experiences with pot and other drugs and who will determine whether our industry flourishes or flounders. What does each generation want, need, and expect from us: our products, dispensaries, stores, services, information, self-regulation and government regulation, and marketing? Chuck Underwood, one of the pioneers of generational study, author of the most comprehensive book on generational business strategies, and host of the television series AMERICA’S GENERATIONS WITH CHUCK UNDERWOOD, will introduce us to The Generational Imperative.
              12:45 PM1:35 PM
              (Workshop Presentation) Learn the ins and outs of cannabis cultivation from seasoned operator Alex Cooley of Solstice. Gain understanding of the process and practices from selecting a site to creating a finished product. Unique format that takes you through the steps but significantly engages audience members via an AMA format.
              1:50 PM2:40 PM
              (Panel Discussion) The production game will change dramatically once cannabis goes from a controlled medicine to a recreational choice. Demand will skyrocket, stretching the capabilities of a small number of currently-sanctioned producers. At the same time, growers best not to get too far ahead or fall behind as bureaucracies implement new legislation at “government speed.” This panel presents the producers’ best prep plan, taking into account the legislative timetable and anticipated sales boom stats.
              Moderator: James Zaza, President & CEO, Zaza Financial Group
               
              1:50 PM2:40 PM
              (Keynote & Panel Discussion) Some traditional financing routes have been blocked for cannabis industry entrepreneurs, with many banks and finance companies refusing to finance them as a matter of policy. But, like nature, business abhors a vacuum. Private investors and micro-loan managers have stepped up where the big banks won’t. This panel is all about the ad hoc investor network that is quickly filling the void for seed money.
              Keynote & Moderator: Hugo Alves, Partner, Corporate/Commercial, Bennett Jones LLP
               

              • Brian Lawson
                VP Commercial & Region Head, Member Experience, Alterna

              • Hugo Alves
                Partner - Corporate/Commercial, Bennett Jones LLP

              • James Black
                VP, Listings Development, Canadian Securities Exchange

              • John Fowler
                President & CEO, Supreme Pharmaceuticals Inc.

              • Sumit Mehta
                Startegy & Finance Consultant, The Arcview Group
              1:50 PM2:40 PM
              (Bonus Session) Many patients who are prescribed marijuana do not want to smoke it, and with the negative effects of smoking tobacco now well known it is not surprising that physicians do not want them to either.  The alternative is finding edible forms of cannabis, of which there seems to be an abundance.  This budding field of culinary exploration is yielding some enticing results.  Watch this enlightening expedition through the variety of ways in which cannabis can be used to achieve medical treatment goals.
              2:50 PM3:30 PM
              (Bonus Session: Celebrity Interview on Main Stage) To music legend Melissa Etheridge, there is no divide between medicinal and recreational marijuana. "I believe anybody who smokes cannabis is using it medicinally," she says. Etheridge, whose company Etheridge Farms is a producer of newly-legalized cannabis products in California, turned to the herb for help in the successful treatment of breast cancer 13 years ago. But whether it’s used to de-stress or stave off nausea, she is an advocate. And her story is an inspiration for the industry.
              Interviewers: Alan Cross, Broadcaster, Brain Dead Dog Productions & Andrea Crawford, Canadian Broadcast Sales
               

              • Alan Cross
                Broadcasting/New Media & Content Creatio/Voiceovers, Brain Dead Dog Productions

              • Andrea Crawford
                Broadcaster, Canadian Broadcast Sales

              • Melissa Etheridge
                Singer/Songwriter, Entrepreneur, Etheridge Farms
              3:30 PM4:00 PM
              (Outside Conference Seminar Rooms) For Delegate Badge Holders.
                3:35 PM4:00 PM
                (Comedic Performance) Comedian Mike Rita is exactly what you think a comic should be, Funny, Smart, & Relate-able. Winner of the Cream of Comedy and The Host Of Stoner Sundays on Pot.Tv, this Toronto native has quickly branded himself as one of Canada’s hottest Comedic Performers. He can be seen Regularly At Yuk Yuk’s Comedy Clubs & At Vapor Central in Toronto.
                4:00 PM4:50 PM
                (Panel Discussion) Whatever framework the marijuana industry adopts in Canada, it won’t be as simple or as cheap as planting seeds and harvesting plants. There will be cost drivers in bringing the product to market, regulatory requirements, intellectual property issues, licenses and standards. Pricing structures will be pushed up by costs and pushed down by competition. This session will take a cold, hard look at the return-on-investment to be expected in the new weed order.
                Moderator: Deepak Anand, Executive Director, MBA, Canadian National Medical Marijuana Assoc.

                Presented by: Kwantlen Polytechnic University (KPU)

                kpu-mark_cmyk-website  

                • Deepak Anand
                  Executive Director, MBA,, Canadian Nat'l Medical Marijuana Assoc.

                • Jason Moscovici
                  Lawyer/Biochemist, ROBIC, LLP

                • Jim Pelton
                  Executive Director, Continuing & Professional Studies, Kwantlen Polytechnic University

                • Kent Hovey-Smith
                  Partner and VP of Corporate Affairs, Tidal Health Solutions

                • Nathan Mendel
                  Founder & President, Your Green Contractor (YGC)
                4:00 PM4:50 PM
                (Panel Discussion) This session will provide Canadian insights from the Cannabis Consumer Update. They include: who is using, how much cannabis, in what form. We will also cover findings regarding strain awareness and trial as well as important consumer attitudes such as: price/quality, impression of Producers, usage occasions and more.
                Moderator: Sunny Freeman, Resources Report, Financial Post
                 
                5:00 PM5:50 PM
                (Panel Discussion) The black market has been the only game we’ve known since the Jazz Age. But now that legalization looms, the players in a legitimized cannabis industry are searching for best-case distribution scenarios. Liquor stores have experience in serving responsible adults while keeping product out of the hands of minors. Dispensaries have specialized expertise. Pharmacies do too with medical expertise to boot. And major chains like Shoppers Drug Mart already want in. This panel will look at the best cases for each market scenario.
                Moderator: Dr.Paul Roumeliotis, Medical Health Officer, Child Health & Wellness for Parents Worldwide, Eastern Ontario Health Unit
                 
                5:00 PM5:50 PM
                (Panel Discussion) The full legalization of cannabis in Canada puts this country and its industry on a very different path from the U.S., given that there are many states along with the U.S. federal government that still criminalize its possession.  And while there are growing opportunities for bilateral trade between Canada and other countries, considerable challenges remain in creating an international market.   What are the differences and similarities between the regulatory regimes of both countries as well as elsewhere in the world, and the challenges these represent that would affect cannabis producers and distributors who are seeking partnerships and cross-border investment?   What impact does full legalization have for producers seeking new avenues for export and trade under both NAFTA and other trade agreements?  Will we face claims of unfair competition from pot-friendly States?  Legal action from criminalized ones?  And how easy will it be for grow-op experts to get visas?
                Moderator: Margaret Nelligan, Partner, Aird & Berlis LLP
                 
                6:00 PM7:00 PM

                Musical Performances By: 54.40 & Exco Levi and High Priest
                  Presented by mnp_logo343c_tag_stacked_for_web

                DAY 2:  CONFERENCE & EXPO
                April 23, 2017
                8:30 AM9:30 AM
                *Ticketed Event* At O’ Cannabiz, we see an opportunity to create an evolved, glass-ceiling-free business environment from square one. This networking breakfast allows female entrepreneurs to share their experiences, challenges and successes with other women in the cannabis business. There are inspirational stories to be heard, and relationships to forge.
                KEYNOTE: Jodie Emery, Political Activist
                Moderator: Noa Kahner, CEO, Kahner Global
                 
                9:00 AM9:45 AM
                (Exhibit Hall - Grand Ballroom) For Delegate Badge Holders & Exhibitors.
                  9:40 AM9:45 AM
                  Join us for the day’s opening remarks - a must-attend to make sure you don’t miss a thing!
                    9:45 AM10:30 AM
                    (Opening Keynote) Recently, the therapeutic potential of phytocannabinoids, the unique active compounds of the cannabis plant, has been rediscovered for many types of illness.  More than 120 phytocannabinoids have been identified within the cannabis plant making this plant complicated and difficult to predict specific clinical effects of cannabis treatment in a patient. Our lab investigates the therapeutic potential of phytocannabinoids when on-top on other studies conducting in the lab, the main focus is on cancer, epilepsy and glucose metabolism (diabetes). These studies relay on our abilities to characterize all the cannabis components. In Addition to ‘basic science’, our lab collaborates with cannabis growers, clinicians and major manufacturers and distributors of medical cannabis. In this work, we are creating the "medical cannabis database" which together with a simultaneous laboratory research and clinical trials, aim to provide physicians with the necessary information to enable them to reach evidence based decisions when prescribing cannabis treatment.

                    • Dr. Deidi Meiri
                      Principal Investigator, Technion Israel Institute of Technology, Laboratory of Cancer Biology and Cannabinoid Research
                    10:40 AM11:20 AM
                    (Presentation) The emerging field of cannabinoid medicine is similar to the field of neuroscience or personalized medicine, where new advancements in diagnostics, software, and treatments have changed the way medicine is practiced. Yet cannabis research in the United States and other countries is restricted by numerous legal, financial, and social stigma hurdles due to its placement as Schedule IV of the Single Convention on Narcotic Drugs. An overview of cannabis research past, present and future will highlight how much yet how little we know. Strategies to obtain funding and approval for cannabis research, methods to standardize data collection and analysis, publication opportunities, and product development pipelines will be reviewed. Opportunities to collaborate on research, share data, and advocate for smart cannabis policy through IMPACT Network will be presented.
                    10:40 AM11:20 AM
                    Presentation #1 As a cannabis business professional in today's industry, you cannot underestimate the importance of compliance. Manufacturers and distributors of infused products in particular face significant challenges navigating the often inconsistent patchwork of packaging and labeling laws instituted by states and local municipalities. And federal agencies are paying attention, too. Cannabis companies have received warning letters from FDA officials for making unapproved health claims about the benefits of CBD, and for misrepresenting the total cannabinoid content in their products. The FDA has even organized a cannabis task force to address the growing unregulated cannabis market. This presentation will help attendees understand the role of federal, state, and local labeling laws in regulating their infused products. It will provide guidance and best practices based on lessons learned in California, Colorado, Washington, and elsewhere. Attendees will leave with a better understanding of how to use compliance as a value differentiator for their business, and how to protect consumers with clear and unambiguous labels.
                    Presentation #2 With multiple competitors vying for a limited consumer base and hundreds of prospective cannabis suppliers seeking a license from regulators, brand value is more important than ever to commercial success in the Canadian medical cannabis industry. Omissions or misinformation on the labels and packages of finished cannabis products will risk attracting regulatory scrutiny, enforcement and erode consumer confidence. This presentation will demystify the requirements for labelling and packaging for cannabis products to maximize compliance, maximize goodwill associated with brandingand minimize reputational risk in this heavily scrutinized industry.  Cannabis entrepreneurs and seasoned operators alike will leave with a clear understanding of what information must be included on their label,  how these products must be packaged and how to avoid common pitfalls. The government continues to break ground on the legalization of cannabis and the labelling and packaging of cannabis for recreational use will likely be informed by the current standards and requirements for regulated products. We offer our insights into the ways in which labelling for the medical and recreational market are likely to differ, which may be helpful to those capitalizing on the emergence of a legal cannabis market.
                    10:40 AM11:20 AM
                    (Bonus Session: Panel Discussion on Main Stage) The increased use of cannabis for medical purposes and announcements by the federal Liberal government that legislation paving the way to its legalization for recreational use is imminent has garnered headlines and created a sensation worldwide.  What is also gaining recognition is the potential for cannabis and hemp-based products for use in the treatment of various medical conditions for our furry quadrupedal companions. However, while the potential benefits may be great, it does not come without significant risk to your pet if not handled properly.  This session will give you a primer on the potential for treatment, the hazards of incorrect dosing and not pet-proofing your ‘stash’.
                    Moderator: Fiona Brown, Aird & Berlis
                     
                    11:30 AM12:20 PM
                    (Panel Discussion) If a product is legal for sale, it follows that sellers will want to spread the word. And a marketplace of sellers will be jockeying to create preferential brand awareness. Yes, that means some form of advertising and marketing. But what pot ads will look like in a regulated environment is still unclear. Will there be restrictions on “lifestyle” ads? On mascots because of the appeal to youth? Will some media, like TV, be off-limits? This is one commercial break that’s definitely worth your time.
                    Morderator: Dooma Wendschuh, Co-Founder & CEO, Province
                    Presented by: Rouge Media Group rouge-media-group-logo-01-1
                    11:30 AM12:20 PM
                    (Panel Discussion) This interactive panel discussion will focus on the importance of cannabis testing and the need for unified methods and testing standards. You will hear from Tracy Ryan of CannaKids who will speak to the need for medical cannabis products to be free of contaminants and for accurate cannabinoid dosing and potency labeling when dealing with pediatric and adult patients. Robert Clifford, PhD will discuss the different analytical instrumentation used for cannabis testing. Douglas Rennie will discuss the need for agreement in unified methods and standards associated with cannabis testing, as well as share his insights on past and current efforts by the AOCS in the development of unified methods and standards in a wide variety of industries for over 100 years. Lastly, Josh Crossney will lead the discussion and discuss the importance of bridging the gap between analytical sciences and cannabis, including information where experts and novices alike can network and learn more.
                    Moderator: Josh Crossney, President & Founder, jCanna & Cannabis Science Conference
                       
                    12:20 PM1:00 PM
                    12:20 PM1:00 PM
                    (Bonus Session: Presentation on Main Stage) So you want to grow your own?  As medical marijuana use has expanded, many patients are trying to grow their own plants with varying rates of success.  While this has been legal in small quantities in Canada since 2016, growing for recreational use is currently not, though that may soon change.  Whatever the purpose, this session will cover the basics of setting up the ideal home grow the right way to avoid costly mistakes.
                    1:00 PM1:40 PM
                    (Presentation) Join Gordon for a candid and informative talk on the real world of cannabis laboratory testing and it's impact on the industry.  He will explore subjects from pseudo testing, lab economics, client interaction, the regulatory role, consumer safety and predictions of what may be around the corner as the industry matures.
                    1:00 PM1:40 PM
                    (Panel Discussion) Celebrity recreational use has already helped destigmatize marijuana. And in future, all kinds of spokespeople could play a part in the normalizing and marketing of it. Celebs as diverse as Jennifer Aniston, Miley Cyrus, Brad Pitt, Bill Maher, Kirsten Dunst and Woody Harrelson have indicated they are pro-pot. Will endorsing it be considered a good career move? And how influential will they be when it comes to carving market share?
                    Moderator: Leonard Glickman, Partner, Cassels Brock & Blackwell, LLP
                     
                    1:50 PM2:20 PM
                    (Presentation) A presentation on the cannabis marker assisted breeding program, the first of its kind in the cannabis Industry.

                    • Dr. Reggie Gaudino
                      PhD, VP & Scientific Operations and Director of Intellectual Property, Steep Hill Labs, Inc.
                    1:50 PM2:20 PM
                    (Presentation)   Cannabis has been used as a medicine for thousands of years. We have only started to stigmatize this plant over the last century. It is known to help with inflammation, seizures and pain as well as many other ailments. Recent developments have shown that cannabis treatments can be extremely beneficial in treating cancer, epilepsy, autism, chronic diseases, and many other conditions. We all have an Endocannabinoid System in our bodies, but sadly most of us do not understand what is does for us. The Endocannabinoid System as a mechanism for drug interaction is widely unexplored and the true potential for positive impact on human health is unknown. This presentation will provide a physician’s view on medical cannabis, delivered by a Cannabis Therapeutics Specialist trained in Family Medicine and Occupational & Environmental Medicine. Drawing from over 30+ years of experience in both research and patient care, this presentation will highlight the need for better therapies and a new focus on total health care (www.TotalHealthCareTHC.com). It is time to move beyond the misconceptions and misinformation associated with this healing plant. It is time to increase education and reduce incarceration, and to learn more about the healing properties of cannabinoids and other medicines in cannabis. Let’s move beyond the stigmas associated with THC towards total health care.
                    2:00 PM2:45 PM
                    (Bonus Session: Panel Discussion on Main Stage) Experiencing the realities of war and its impact on their fellow soldiers and civilians alike first hand on the ground has always been traumatic.  What is new is the growing awareness of its impact on the mental health of the soldiers themselves and on their families, as well as the increased role cannabis is playing in the successful treatment of PTSD.  Join our veterans as they describe the rocky road that lead them to cannabis as their treatment of choice.
                    2:30 PM3:10 PM
                    (Presentation) Due to the complex structure of the different cannabinoids and terpenes profiles varying from strains-to-strain, cannabis researchers and scientist are only now just scratching the surface in efforts to treat and even cure serious illness. The antidotal data is staggering in contrast to the underfunded anecdotal evidence pales in comparison. One thing is certain that when cannabis is grown in a clean, consistent, and stabilized environment it is optimal for scientific research, as well as patient  consistency.  We will talk about the optimal environmental parameters in which cannabis is grown and how indoor grow facilities are constructed with the overall the goal to minimize the introduction, generation, and retention of airborne particulates, and pest and pathogens within the facility. While maintaining control of all other relevant parameters such as temperature, humidity, and overall room pressure. We will discuss building materials; indoor cultivation techniques are similar to materials used in labs, clean rooms, and commercial kitchens. In addition, we will cover HVAC bio contamination risks and the current climate of medical research.
                    2:30 PM3:10 PM
                    (Presentation) Using Medical Cannabis for Opioids Sparing and Tapering in Chronic Pain". The presentation provides literature on the topic, and he will discuss how medical cannabis can be used as an adjunct medication for opioid sparing or withdrawal. He will focus on how cannabis has effects on opioid and cannabinoid receptors and is much safer than opioids. Dr. Smith will provide education on how to use medical cannabis for opioid sparing and withdrawal.
                    3:10 PM3:30 PM
                    (Outside Conference Seminar Rooms) For Delegate Badge Holders.
                      3:10 PM3:40 PM

                      Musical Performance By: Exco Levi and High Priest
                      Jamaican/Canadian musician Exco Levi pays tribute to the founders of reggae music through a modern twist of poetry and sound. On a mission to deliver his message to the world, Exco has performed multiple European tours, California’s Reggae On the River, Spain’s Rototom, Canada’s major reggae festivals (including Jambana™ One World Festival) and even a feature performance in Zimbabwe. This multiple award winning artists songs are just as potent on his lips as they are on record and his ability to quickly engage and convince his audience has led to him being in high demand for many colourful collaborations including Busy Signal, Chronixx, Kabaka Pyramid, Donovan Germaine and other top Artists, Djs, promoters and producers worldwide.

                      • Exco Levi
                        Musician, Exco Levi and High Priest
                      3:30 PM3:55 PM
                      (Featured Keynote) Maya will be speaking about how to keep cannabis compassionate, treating cannabis as a superfood and healing herb with a focus on respecting the farmer and keep our industry full of integrity.

                      • Maya Elisabeth
                        CEO of Whoopi and Maya and Owner & Founder of Om Edibles, Om Edibles
                      4:00 PM4:40 PM
                      (Panel Discussion) To those who say there hasn’t been enough testing of marijuana, Tommy Chong once said, “I’ve been testing it for 50 years.” Ironically, he has a point. From sheer mass use, there is plenty we do know about the efficacy of cannabis as a medicine, as well as cautionary notes. Physicians who prescribe it have a pretty good idea what it can do, what it can’t, and how it should be applied.  In this session we separate facts from fiction.
                      Moderator: Dr. Danial Schecter, Executive Director, Cannabinoid Medical Clinic
                       
                      4:00 PM4:40 PM
                      (Panel Discussion) One worker’s medicine is another’s asthma attack. And regulatory loosening of marijuana will almost certainly cause a paradigm shift from pee-in-a-cup disciplinary programs to accommodation on medical grounds. Everything from human rights laws to workplace safety regulations to common courtesy will be in play as employers and employees seek common ground on all new territory. This panel will identify and sort out some of the biggest issues.
                      Moderator: Lorenzo Lisi, Partner, Aird & Berlis LLP, Canada
                       
                      4:45 PM5:30 PM
                      (Closing Keynote) Tracy Ryan’s daughter Sophie was diagnosed with a rare brain tumor at 8 1/2 months old. After watching her own daughter defy every odd medical doctors placed against her that was a result of her cannabis oil use, Tracy launched CannaKids and SavingSophie.org. Tracy has consulted with thousands of patients around the globe on cannabis use and education, and has treated over 500 patients in the last year and a half in California with her own line of CannaKids’ Honey Gold cannabis oils. With a true passion for clinical research, Tracy has successfully secured a relationship with the Technion Institute in Israel who are leading the way in cannabis research for cancer. Her team is additionally expected to start clinical trials in the pediatric cancer sector in hospitals later this year. As a cancer mom, advocate, caregiver, cannaprenuer and research pioneer, Tracy’s fire is fueled by the desire to find her daughter a cure, and all of the patients behind her, the answers they need to help end their suffering.